Weight Loss Drugs Boost Job Prospects for Unemployed US Women, Study Finds

A groundbreaking new study by Harvard economist Rebecca Diamond reveals that unemployed women in the US who use GLP-1 weight loss medications significantly increase their chances of finding a job. After 18 months, women taking these drugs saw a 27 percentage point jump in employment compared to those who wanted to use them but hadn't yet started. This striking finding suggests these popular medications are doing more than just helping with weight loss; they're actively reshaping career paths. The research, published as a working paper by the National Bureau of Economic Research, points to a 'female obesity penalty' in the job market, where heavier women often face discrimination, particularly during initial hiring processes. The study found that GLP-1s, like Ozempic and Wegovy, seem to impact 'first impressions,' as already employed women did not experience similar career advancements after starting the drugs. Interestingly, single women on GLP-1s also saw a nearly 29 percentage point increase in marriage or cohabitation rates, hinting at a broader social impact beyond just employment. While the drugs present a new path to economic mobility for many, the findings raise important ethical questions about the societal pressure on appearance and the fairness of a system where medical treatment might become a 'remedy for discrimination'. With GLP-1 usage quadrupling since 2024 and significant healthcare costs involved, the study underscores growing concerns about equitable access to these life-altering medications and their long-term effects on the US labor market and social equity.